{"disease":{"id":"juvenile-dermatomyositis","name":"juvenile dermatomyositis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT00059748","title":"Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT05879419","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2005,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT03430388","title":"Yellow Fever Vaccine in Patients With Rheumatic Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT01276470","title":"Environmental Risk Factors for the Anti-synthetase Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":580,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT07111065","title":"FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT05000216","title":"COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":258,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06888973","title":"Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","has_results":false},{"nct_id":"NCT00323960","title":"Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"Istituto Giannina Gaslini","has_results":true},{"nct_id":"NCT07138157","title":"Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT05545839","title":"Transition to Adulthood Through Coaching and Empowerment in Rheumatology","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT02245841","title":"Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"The Cleveland Clinic","has_results":true},{"nct_id":"NCT06686524","title":"Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT05524311","title":"Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05509140","title":"Clinical Analysis of Juvenile Dermatomyositis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT07184450","title":"Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":11,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT06556992","title":"Fitness Integrative Training for Pediatric Rheumatology Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06569472","title":"Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT01724580","title":"Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Eli Lilly and Company","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}